Hemostasis Diagnostic Devices And Equipment Market Growth Analysis And Key Drivers, Forecast To 2033


Posted April 8, 2024 by ravali

Global hemostasis diagnostic devices and equipment market size is expected to reach $9.85 Bn by 2028 at a rate of 12.3 % segmented as by product, analyzers, coagulation instrument, other hemostasis instruments, reagents and kits
 
Overview and Scope
Hemostasis is the process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. With the help of hemostasis diagnostic devices, the cause of bleeding during surgery can be predicted by identifying any hemostatic defects in patients.

Sizing and Forecast
The hemostasis diagnostic devices and equipment market size has grown rapidly in recent years. It will grow from $5.48 billion in 2023 to $6.18 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to clinical diagnostics, surgical procedures, anticoagulant therapy monitoring, hemophilia and bleeding disorders.

The hemostasis diagnostic devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $9.85 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to aging population, cardiovascular and chronic diseases, personalized medicine, rising surgical procedures. Major trends in the forecast period include point-of-care testing, automation and robotics, biomarker discovery, telemedicine and remote monitoring.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Segmentation & Regional Insights
The hemostasis diagnostic devices and equipment market covered in this report is segmented –

1) By Product: Analyzers, Coagulation Instrument, Other Hemostasis Instruments, Reagents and Kits
2) By Device Technology: Automated, Semi-Automated, Manual
3) By End User: Hospitals, Clinics, Independent Diagnostic, Laboratories, Other End Users

North America was the largest region in the global hemostasis diagnostic devices and equipment market in 2023. Asia-Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2598&type=smp

Major Driver Impacting Market Growth
The increased likelihood of older people being diagnosed with a disease is driving the number of surgeries for cardiovascular diseases (CVD) using hemostasis devices. Due to the higher incidence of diseases with advancing age, there is an increase in the number of surgeries for elderly patients nowadays. These hemostasis devices are very efficient in speeding up the natural process of clotting in the blood and can monitor anticoagulation and transfusion therapy guidance in any surgery. According to the American Heart Association report, Americans older than 80 have a high risk of developing cardiovascular disease (CVD) around 83% of men and 87.1% of females will be suffering from any form of CVD, therefore, to improve the comfort of the patient and the success rate of surgeries as a result hemostasis device has been implemented widely.

Key Industry Players
Major companies operating in the hemostasis diagnostic devices and equipment market include C. R. Bard Inc., Baxter International Inc., Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Chrono-Log Corporation, CSL Behring LLC, F. Hoffmann-La Roche Ltd., Grifols S.A., HemCon Medical Technologies Inc., Integra Life Sciences Corporation, Medtronic plc, Siemens AG, Thermo Fisher Scientific Inc., Trinity Biotech plc., Ethicon Inc., Boston Scientific Corporation, Olympus Corporation, Cook Group Inc., Halyard Health, Medline Industries Inc., ConMed Corporation, Moog Inc., Argon Medical Devices Inc., B. Braun Interventional Systems Inc., Bio-Rad Laboratories Inc., CareFusion Corporation, Danaher Corporation, DemeTECH Corporation, Diagnostica Stago SAS, Dolphin Sutures, EndoEvolution LLC, Haemonetics Corporation, Internacional Farmacéutica S.A. de C.V., Merit Medical Systems Inc., Quidelortho Corp, STAGO, Stryker Corporation

The hemostasis diagnostic devices and equipment market report table of contents includes:
1. Executive Summary
2. Hemostasis Diagnostic Devices And Equipment Market Characteristics
3. Hemostasis Diagnostic Devices And Equipment Market Trends And Strategies
4. Hemostasis Diagnostic Devices And Equipment Market - Macro Economic Scenario
5. Global Hemostasis Diagnostic Devices And Equipment Market Size and Growth
6. Hemostasis Diagnostic Devices And Equipment Market Segmentation
7. Hemostasis Diagnostic Devices And Equipment Market Regional And Country Analysis
.................
33. Key Mergers And Acquisitions In The Hemostasis Diagnostic Devices And Equipment Market
34. Hemostasis Diagnostic Devices And Equipment Market Future Outlook and Potential Analysis
35. Appendix

List Of Tables :
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Device Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
.........
Table 74: C. R. Bard Inc. Financial Performance
Table 75: Baxter International Inc. Financial Performance
Table 76: Pfizer Inc. Financial Performance
Table 77: Johnson & Johnson Financial Performance
Table 78: Abbott Laboratories Financial Performance

Explore the trending research reports from TBRC:
https://topprnews.com/fetal-and-neonatal-monitoring-devices-market-statistics/
https://goodprnews.com/fruit-and-nut-farming-market-trends/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By tbrc
Country United Kingdom
Categories Health
Last Updated April 8, 2024